Related Experiment Videos
Hürthle cell tumors: applying molecular markers to define a new management algorithm
Evelyn L Maxwell1, Carsten E Palme, Jeremy Freeman
1Department of Otolaryngology-Head and Neck Surgery, Mount Sinai Hospital, University of Toronto, 600 University Avenue, Rm. 401, Toronto, Ontario, Canada M5G 1X5.
Archives of Otolaryngology--Head & Neck Surgery
|January 18, 2006
Summary
A new algorithm for Hürthle cell tumors combines histology and molecular markers. This approach aids in managing Hürthle cell carcinoma and its variants, improving patient outcomes.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Hürthle cell tumors are a variant of thyroid cancer with variable behavior.
- Accurate diagnosis and management are crucial for effective treatment.
- Current management strategies may benefit from integration of molecular markers.
Purpose of the Study:
- To develop a novel management algorithm for Hürthle cell tumors.
- To incorporate histopathologic findings and ret/PTC molecular markers into the algorithm.
- To improve diagnostic and therapeutic strategies for Hürthle cell lesions.
Main Methods:
- Retrospective review of 45 Hürthle cell carcinoma cases over 22 years.
- Statistical analysis of tumor and treatment variables, including survival rates.
- Kaplan-Meier analysis for disease-free and disease-specific survival.
Main Results:
- High incidence of Hürthle cell carcinoma with cervical metastasis observed.
- Vascular invasion significantly correlated with poorer survival outcomes.
- Treatment factors did not significantly impact recurrence or survival rates.
Conclusions:
- A significant proportion of Hürthle cell carcinomas present with regional metastases.
- Proposed algorithm integrates histopathology and ret/PTC molecular assays for tailored management.
- Recommends completion thyroidectomy for ret/PTC-positive tumors and observation for ret/PTC-negative adenomas.